INTRODUCTION
Lipoxygenases (LOXs) constitute a family of lipid peroxidizing enzymes, which metabolize polyunsaturated acids to biologically active mediators. Mammalian LOXs and their products have been implicated in cellular defense response and in numerous pathophysiological conditions. 1-4 Since their discovery, 12/15-LOXs have been believed to function as monomers possessing a single binding site for substrate and product. Experiments with 15(S)-hydroperoxyeicosa-5(Z),8(Z),11(Z),13(E)-tetraenoic acid (15(S)-HpETE) indeed indicated covalent linkage of this endogenous LOX product to rabbit 12/15-LOX active-site peptides with a stoichiometry close to equimolar. 5 Earlier investigations into the solution structure of 12/15-LOX have shown that the rabbit enzyme occurs mainly as hydrated monomer 6 supporting the traditional concept of LOX catalysis. 7 However, more recent small-angle X-ray scattering (SAXS) experiments suggested the possibility of a monomer-dimer equilibrium between 12/15-LOX protomers, 8 which is controlled by the physiochemical environment (ionic strength) ABSTRACT Mammalian lipoxygenases (LOXs) have been implicated in cellular defense response and are important for physiological homeostasis. Since their discovery, LOXs have been believed to function as monomeric enzymes that exhibit allosteric properties. In aqueous solutions, the rabbit 12/15-LOX is mainly present as hydrated monomer but changes in the local physiochemical environment suggested a monomer-dimer equilibrium. Because the allosteric character of the enzyme can hardly be explained using a single ligand binding-site model, we proposed that the binding of allosteric effectors may shift the monomer-dimer equilibrium toward dimer formation. To test this hypothesis, we explored the impact of an allosteric effector [13(S)-hydroxyoctadeca-9(Z),11(E)-dienoic acid] on the structural properties of rabbit 12/15-LOX by small-angle X-ray scattering. Our data indicate that the enzyme undergoes ligand-induced dimerization in aqueous solution, and molecular dynamics simulations suggested that LOX dimers may be stable in the presence of substrate fatty acids. These data provide direct structural evidence for the existence of LOX dimers, where two noncovalently linked enzyme molecules might work in unison and, therefore, such mode of association might be related to the allosteric character of 12/15-LOX. Introduction of negatively charged residues (W181E 1 H585E and L183E 1 L192E) at the intermonomer interface disturbs the hydrophobic dimer interaction of the wild-type LOX, and this structural alteration may lead to functional distortion of mutant enzymes. and the protein concentration. In contrast to the observations made in solution, the crystallographic 12/15-LOX-inhibitor complex 9 represents a dimer, which consists of two structurally different conformers A and B that are associated via their a2 helixes. In this structure (PDB 2P0M entry), one monomer (conformer B) carries the inhibitor within the putative substrate-binding pocket, whereas the other one is not liganded (conformer A). It is still unclear whether the intermolecular contacts in the crystals represent a biologically relevant structure or may be considered as an ''in vitro artifact'' induced during crystal grown at high ionic strength. If dimerization is biologically relevant, active-site ligands might play a role as molecular trigger that augments the weak protein-protein interaction between 12/15-LOX molecules forcing dimer formation. Modeling of the interface contacts between two 12/15-LOX molecules suggested that the geometry reported in the crystals for dimers (A:B) appears to be thermodynamically the most favorable with a solvation free energy of 225 kcal/mol. 8 There are numerous examples in the literature characterizing the cross-talk between monomeric subunits of highly organized protein oligomers. Such protein-protein interactions frequently involve both weak and stronger transient associates, in which obligate homodimers as well as nonobligate heterodimer complexes are present. 10-13 An excellent example of such cooperativity between the two subunits of obligate homodimeric protein has recently been ascribed to cyclooxygenase-2 (COX-2), another lipid peroxidizing enzyme. In COX-2, one monomer acts as an ''allosteric'' subunit modulating the catalytic efficiency of its partner monomer. 14,15 Also, mammalian LOXs have been shown to exhibit allosteric properties. Although functional data suggest that binding of endogenous product, 13(S)-H(p)ODE, appears to lock the enzyme in a catalytically competent state, the 13(S)-H(p)ODE-binding region(s) have not been identified. 16, 17 Because the allosteric character of the enzyme can hardly be explained using a single ligand binding-site model, we proposed that the binding of allosteric effectors such as 13(S)-H(p)ODE may induce conformational changes so that transient dimeric complex may be formed.
To explore whether binding of allosteric effectors may induce intermolecular association of 12/15-LOX protomers in aqueous solutions, we applied SAXS. To diminish unwanted side effects and unspecific ligand binding to the protein, we refrained from using 13(S)-hydroperoxyoctadeca-9(Z),11(E)-dienoic acid (13(S)-HpODE) as allosteric effector but selected 13(S)-hydroxyoctadeca-9(Z),11(E)-dienoic acid (13(S)-HODE) instead. Unlike the situation with the enzymatic product 13(S)-HpODE, examining of the cross-talk between the 12/15-LOX protomers in the presence of fatty acid substrate is technically more challenging owing to the high interconversion rate of these natural ligands. Previous docking calculations combined with molecular dynamics (MD) simulations on the rabbit 12/15-LOX-arachidonic acid (AA) complex suggested that enzyme-substrate interaction induces similar structural alterations as observed in the crystallographic conformer B upon inhibitor binding. 18 To find out whether 12/15-LOX is able to form transient intermolecular associates that are also stable in the presence of substrate, we created in silico dimer models (where conformer A is an ''empty'' molecule and conformer B contains AA at the active site) and performed MD simulations.
MATERIALS AND METHODS

Protein preparation
The recombinant wild-type rabbit 12/15-LOX and the mutants were expressed in E. coli as His-tagged fusion and purified using affinity chromatography on nickelagarose followed by anion-exchange and size exclusion chromatography columns as described in protocol. 8 After gel filtration, the corresponding protein solutions in 20 mM Tris-HCl buffer, pH 8.0 were concentrated either to 0.7 or to 1.0 mg/mL with a Spin-X R 6 30k MWCO concentrator (Corning, UK) and frozen in the presence of 5% (vol.) glycerol in liquid nitrogen. The protein concentration was estimated spectrophotometrically at 280 nm using molecular extinction coefficients 1.78 mg/(mL cm) for the wild-type enzyme and the L183E 1 L192E mutant but 1.70 mg/(mL cm) for the W181E 1 H585E mutant. Enzyme-ligand complexes were prepared immediately before each SAXS measurement by adding the corresponding amounts of a 47 mM 13(S)-HODE solution to the protein sample. The mixture was incubated for 15 min on ice and centrifuged at 14,000g for 30 min at 58C.
SAXS data collection and analysis
The SAXS measurements were performed at the EMBL BioSAXS beamline X33 at the DORIS storage ring 19 (DESY, Hamburg) using the X-ray wavelength of 1.54 Å and the sample-to-detector distance of 2.7 m. A noisefree photon-counting PILATUS detector was used to record four consecutive frames of 30 s, which were averaged after confirming the absence of radiation damage. An automatic sample changer was used in all measurements to facilitate loading the samples and cleaning the cell windows made of mica or polycarbonate films. 20 The scattering patterns of the corresponding buffer solutions were recorded before and after the measurements of the protein sample, and then the averaged buffer patterns were subtracted from the protein patterns. Bovine serum albumin solution of 4.6 mg/mL in 50 mM Hepes, pH 7.5, was used for calibration of the molecular mass. The samples of wild-type rabbit 12/15-LOX, its mutants, and the enzyme-ligand complexes were kept at 108C and measured at the protein concentration of 0.7 mg/mL for the wild-type enzyme, 0.7 mg/mL for the W181E 1 H585E mutant, and 1.0 mg/mL for the L183E 1 L192E mutant. Several independently prepared solutes of protein samples were applied for the measurements, and only those that were not affected by aggregation were considered for further analysis. All samples for the rabbit LOX were scattered to a nominal resolution of 30 Å . Data reduction and Guinier analysis were performed using the program PRIMUS. 21 For polydisperse samples, an improved version of the SASREF program was used, 22 allowing the simultaneous consideration of polydispersity and free movement of defined rigid subunits. The radius of gyration for the wild-type enzyme in the crystal lattice was evaluated from the crystal structure 2P0M using the program CRYSOL. 23 To assess the volume fractions of the individual species in the mixture, the SAXS curve was represented by a linear combination of the theoretical scattering profiles calculated from the crystal structures or the rigid body models of the relevant components in solution using the program OLIGOMER. 21 The structure of the conformer A was refined using two major domains (A:2-108|A:109-663), and the dimer (A:2-108|A:109-663, A109-663|A:2-108) was generated via P2 symmetry operation. The catalytic domains (109-663) were fixed to keep the dimer interface similar to that in the crystal (2P0M), but the N-terminal domains (2-108) were allowed to move freely. Additionally, a tetramer model in P222 symmetry for the ligand-bound L183E 1 L192E mutant was constructed using the program SASREF, 22 and the volume fractions for the ligand free mutant were assessed using the program OLIGOMER. 21
Kinetic assay system
Oxygenation kinetics were assayed by absorption spectrometry (Shimadzu 2100 spectrophotometer) measuring the increase of absorbance at 235 nm in the substrate concentration range between 1 and 50 lM. The assay mixture was a phosphate buffered saline (PBS), pH 7.4, containing either 56 nM or 165 nM enzyme, normalized to a 1:1 stoichiometry of apoenzyme and nonheme iron. The reaction was started by addition of substrate. All measurements were carried out at room temperature.
Molecular dynamics simulations of the enzyme-substrate complex for wild-type and double mutant dimers Homodimeric models (conformer A and B) of 12/15-LOX with AA bound in the conformer B were built for the wild-type enzyme and the W181E 1 H585E and L183E 1 L192E double mutants. The initial coordinates for the wild-type enzyme dimer were taken from the crystallographic structure (PDB entry code 2P0M). Crystallographic water molecules were also considered in the model. The Fe(III)-OH 2 cofactor was built in both monomers considering the octahedral coordination of the iron. AA was positioned inside the active site according to the docking results obtained in our previous work on conformer B. 18 The missing hydrogen atoms were built with the HBUILD facility in the CHARMM package (version c35). 24 The construction of the two double mutants (W181E 1 H585E and L183E 1 L192E) was done in silico by changing the side chain of the mutated residues in the wild-type model and searching for the best rotamer in each case. The program Chimera-version1.5.2 25 was used for this purpose. Each of the dimeric models was submitted to MD simulations to get an indicator of the stability of the interface and compare mutated enzymes with the wild-type one. The complexes were solvated with a 151 Å 3 121 Å 3 73 Å box of preequilibrated TIP3 waters. The total charge of the systems was neutralized with the addition of sodium cations. The resulting solvated dimeric systems had a total of $141,713 atoms, among them $41,497 atoms belong to the 1326-amino acid dimer. The simulations were performed at constant pressure and temperature using periodic boundary conditions. The extended system constant pressure as well as the Hoover constant temperature algorithms 26 were used. The PBC was built with the CRYS-TAL module of CHARMM using an orthorhombic unit cell, and the Particle-Mesh Ewald method was used for long-range electrostatics. A time step of 2 fs was used with all the angles and bonds involving hydrogen atoms constrained by the SHAKE algorithm. 27 All the systems were first submitted to some energy minimization steps to relax them. They were then heated and equilibrated to reach the desired temperature (300 K). Restrains were applied to the protein and the ligand, which were gradually released to prevent inaccurate behaviors. Finally, a production period of 4 ns was run. Two independent 4-ns simulations, which differ in the initial assignment of velocities, were run for each dimer. The simulations were done using the CHARMM-22 force field parameters 28,29 for the protein atoms, for the iron and its first coordination sphere we used the parameters specifically developed in a previous work 30 for the same system. The force field topology and parameters for the lipid substrate were derived from the lipids CHARMM-27 ones. 31
RESULTS AND DISCUSSION
Wild-type 12/15-LOX solution structure in the presence and absence of an allosteric effector
Before SAXS measurements, we tested the impact of different 13(S)-HODE concentrations on particle size distribution of wild-type 12/15-LOX in the range between 10 and 100 lM using dynamic light scattering. For the wild-type enzyme (1 lM), a notable increase in the diaTransient Dimers of Mammalian 12/15-Lipoxygenase meter of particles was observed in the range between 10 and 40 lM of 13(S)-HODE (Supporting Information Fig.  S1 ). SAXS measurements were performed first for different wild-type 12/15-LOX preparations in the absence of 13(S)-HODE, and only those samples not affected by protein aggregation were selected for further experimentation. Then, 13(S)-HODE was added at different concentrations and SAXS measurements were repeated. Evaluation of the scattering patterns of ligand-free 12/15-LOX yielded a radius of gyration of R g 5 3.1 AE 0.1 nm, which is higher than the theoretical value of 2.86 nm calculated for the crystallographic conformer A (2P0M). When the protein was incubated with a 10-fold molar excess of 13(S)-HODE, R g increased to 4.2 AE 0.1 nm, a value that is close to the theoretical R g (4.11 nm) calculated for the crystal dimer (conformers A:B). Comparison of experimental and theoretical scattering patterns estimated for the crystal monomer and dimer structures revealed noticeable discrepancies in the region of s < 0.3 nm 21 for both ligand-free enzyme and ligand-containing samples. In addition, we observed systematic deviations in the s-range between 0.6 and 1 nm 21 in the sample with ligand (Supporting Information Fig. S2 ). Considering the absence of any signs of unspecific protein aggregation, this mismatch may be explained by a monomerdimer equilibrium and/or by the movement of the flexible N-terminal domain relative to catalytic subunit (interdomain movement). 8 By using rigid body modeling 22 a linear combination of the calculated scattering curves for the conformer A and P2 symmetry-related dimer models were fitted to the experimental data [ Fig.  1(A) ], and the following conclusions were drawn: (i) The major volume fraction of ligand-free wild-type enzyme in solution was monomeric ($85%) and only $15% of the enzyme was present as dimer.
(ii) In the presence of a 10-fold molar excess of 13(S)-HODE, the volume fraction of the dimer increased to $95%. Thus, in the presence of the allosteric ligand, the monomer-dimer equilibrium was shifted almost completely toward enzyme dimers. (iii) In the refined monomer and dimer models, the N-terminal domain appears to swing away from catalytic unit resulting in a significant increase in the size of enzyme monomers and dimers [ Fig. 1(B) ]. This result, which is in accordance with our previous observations of motional flexibility of the N-terminal b-barrel, suggested that interdomain interface residues might be involved in substrate/ligand binding. 32 (iv) At higher ligand concentrations (40-fold molar excess), the volume fraction of the enzyme dimer slightly decreased to about 80% (Table  I) . Although the mechanistic basis for this decrease has not been explored, it might be related to repulsion between two B-conformers, when more than 50% of LOX molecules are present as liganded B-form. Although smaller structural elements involved in the interaction between two molecules remain undistinguishable at 30 Å , the low-resolution models obtained clearly indicate an overall molecular shape change for the 12/15-LOX:13(S)-HODE complex when compared with ligand-free 12/15-LOX.
SAXS of the 12/15-LOX dimer interface mutants
In rabbit 12/15-LOX crystallographic dimers L179, L183, L188, and L192 form a hydrophobic cluster, in which two leucine residues distanced by one a-helix turn get in direct contact with the corresponding structural motif of the partner monomer that runs in opposite direction [ Fig. 1(C) ]. Such association resembles a leucine zipper motif, 33 a supersecondary structure that functions as dimerization domain generating adhesive forces between two monomers. In addition, W181 of the a2 helix, which has been implicated in membrane binding, 34 interacts with H585 of helix a18 [ Fig. 1(C) ] and, thus, may also contribute to stabilize the dimer interface. If these structural motives are involved in intermolecular association induced by 13(S)-HODE, introduction of charged residues at critical positions is expected to destabilize the entire hydrophobic bound network and thus may prevent dimerization. To find the most suitable candidates for in vitro site-directed mutagenesis studies, each of the residues that supposedly contributed to the hydrophobic interface (Supporting Information Fig. S3 ) was mutated in silico to the other 19 canonic proteinogenic amino acids. On the basis of the free energy calculations, we selected two amino acid combinations (L183E 1 L192E and W181E 1 H585E) for which monomer repulsion in silico was suggested (Supporting Information Table SI), created the corresponding double mutants, and performed SAXS measurements to quantify the degree of LOX dimerization.
Addition of 13(S)-HODE to the wild-type 12/15-LOX induced enzyme dimerization as indicated by the alterations in the X-ray scattering pattern [ Fig. 1(A) ]. In contrast, when we compared the SAXS pattern of the W181E 1 H585E mutant in the presence and absence of the allosteric ligand 13(S)-HODE [ Fig. 2(A) ], we did not observe significant differences. In fact, the calculated R g values for this mutant measured either in the absence or presence of 13(S)-HODE were very similar to that obtained for the ligand-free wild-type enzyme (Table I) .
For the ligand-free L183E 1 L192E double mutant a larger R g 5 3.6 AE 0.1 nm was obtained. When the protein was incubated with 13(S)-HODE, the experimental SAXS profile revealed significant changes in the entire srange from 0.1 to 2.5 nm 21 [ Fig. 2(B) ]. Analysis of the SAXS data for the ligand-bound L183E 1 L192E mutant yields R g 5 4.3 AE 0.1 nm and D max 5 13 AE 1 nm. Although these values are similar to those obtained from the crystal dimer (4.11 and 14 nm, respectively), the distinct plateau in the s-range from 0.8 to 1.3 nm 21 of the SAXS curve suggests that the solute has a different shape [ Fig. 2(B) ]. The ab initio model reveals an excluded volume of 480 AE 10 nm 3 , which is 2.5 times larger than that estimated for dimer from 2P0M (190 nm 3 ). The molecular mass estimated from SAXS data constitutes 230 AE 10 kDa, a value which is three times higher than the mass of 12/15-LOX monomer (75 kDa). These results suggest that enzyme oligomers (trimers or tetramers) appear to be present. Attempts to construct a stable trimer model were not successful, whereas a tetramer model containing the crystallographic conformer A as subunit and applying P222 symmetry did perfectly fit the experimental data with v 5 1.08 [ Fig. 2(B) ].
The R g value calculated for the ligand-free L183E 1 L192E mutant was significantly larger than that obtained for the ligand-free wild-type 12/15-LOX. Assuming a steady state between monomers and dimers, this difference could be explained by an increase in the dimer fraction to $30% (v 5 1.16) (Table II) . On the other hand, the experimental SAXS curve for the ligand-free L183E 1 L192E mutant could be fitted with discrepancy factor of v 5 1.23 to a curve representing a mixture, in which 10% tetramers and 90% monomers were present. If one considers the prediction of monomer repulsion within a dimer as suggested by the free energy calculations (Supporting Information Table SI ), the dimer model becomes Figure 2 Experimental SAXS patterns and fits of models for the double mutants in a ligand-free form and as a complex with 13(S)-HODE. (A) SAXS patterns and the fitted models of refined monomers and dimers for the W181E 1 H585E mutant. The black (1) and the red (2) curves correspond to the samples before and after adding the 40-fold molar excess of 13(S)-HODE, respectively. (B) SAXS patterns and the fitted models of refined monomers and dimers for the L183E 1 L192E mutant. The curve 1 (black) corresponds to the SAXS pattern of ligand-free sample and fit by a linear combination of the scattering from the crystal monomer and a tetramer model in P222 symmetry. The curve 2 (red) corresponds to the sample with ligand and the fit of the tetramer model. (C) Tetramer model of L183E 1 L192E mutant complex with 13(S)-HODE in P222 symmetry. The four catalytic domains are shown in gray color, N-terminal domains in orange, and a2 helixes in red. The structure shows significant difference to the dimer with P2 symmetry where both a2 helixes are tightly associated.
Table II
Analysis of the SAXS Data Obtained for the Wild-Type 12/15-LOX and Its L183E 1 L192E
Ligand amount excess (mol)
Monomer-dimer equilibrium less likely. Moreover, such model cannot be used to explain the experimental SAXS patterns obtained for L183E 1 L192E mutant in the presence of ligand. Structural analysis of the tetramer model suggests that the a2 helixes containing the mutated residues are not tightly associated [ Fig. 2(C) ]. Although this mutant forms larger oligomers in the presence of ligand and W181E 1 H585E does not, our SAXS data clearly indicate that mutations of the amino acids mentioned above may disrupt the original dimer interface present in the wild type.
Kinetic assays reveal pronounced substrate/ product inactivation of the double mutants
To explore the impact of disruption of the original dimer interface of rabbit 12/15-LOX on functional enzyme properties, we assayed the catalytic activity of the wild-type LOX and the double mutants (W181E 1 H585E and L183E 1 L192E) using linoleic acid (LA) as substrate. As shown in Figure 3(A) , the wild-type enzyme follows Michaelis-Menten kinetics and a K M of 21.3 AE 3.6 lM and a maximum turnover rate at substrate saturation (k cat ) of 47.23 AE 2.83 s 21 were determined. In contrast, neither of the double mutants followed Michaelis-Menten kinetics. Instead, they were gradually inactivated at increasing substrate concentration (LA) above 5-15 lM [ Fig. 3(A) ]. A similar effect was also observed in the presence of 13(S)-H(p)ODE [ Fig. 3(C) ]. The molecular basis for this inactivation has not been explored in detail, but substrate inhibition and/or suicidal inactivation by the reaction products may be discussed. In the 12/15-LOX monomers (PDB entry 2P0M) regardless of whether it is conformer A or B, the side chains of the mutated residues would be mainly solvent exposed. Hence, it is unlikely that either of the point mutations at these positions significantly alters the packing of the active site upon substrate binding. In fact, when we created single mutants we hardly observed any effect of the mutations on the catalytic properties (data not shown). On the other hand, the correlation between the protein concentration and the amounts of substrate required for enzyme inactivation [ Fig. 3(B) , shown for W181E 1 H585E] suggested that direct substrate inhibition might be involved. As long as the two wild-type conformers A and B maintain their dimer interface, both hydrophobic a2 helixes are shielded from the solvent environment. However, once the interface is disturbed by the mutations, as it happens in the case of W181E 1 H585E and L183 1 L192E, the a2 helices might come in contact with excessive amounts of fatty acid (LA) and/or allosteric ligand (13(S)-H(p)ODE) to cause inhibition. This assumption is supported by our previous observations indicating a linkage of 15(S)-HpETE to a2 helix residues of rabbit 12/15-LOX. 5 To find out whether 12/15-LOX is able to form similar intermolecular associates in the presence of substrate and whether the proposed mutations disrupt the described interactions, we created in silico dimer models, in which conformer A is an ''empty'' molecule and conformer B contains AA at the active site. 18 Similar models were created for the double mutants (W181E 1 H585E and L183E 1 L192E). Molecular dynamics simulations with periodic boundary conditions were carried out for the fully solvated wild-type enzyme dimer and for each of the mutants. Several free to move sodium cations were included to maintain the systems' neutrality. The analysis of the 4-ns trajectories for the W181E 1 H585E mutant revealed opening of the intermolecular interface [ Fig.  4(A,C) ] along with rearrangement of E585 (conformer A) and E181 (conformer B) side chains to minimize electrostatic repulsions. Separation of the two mutated residues induces penetration of water molecules and eventually a sodium cation into the intermolecular crevice to stabilize this region [ Fig. 4(C) ]. The opening of the interface at that point is also affecting the interface at the hydrophobic part (leucine residues). In the 4-ns simulations, a rotation of conformer A relative to conformer B was observed, which clearly disrupts the original intermolecular interface and reduces its surface area from 1164 AE 49 Å 2 (wild-type enzyme) to 693 AE 10 Å 2 [ Fig.  4(A) ]. In the 4-ns trajectories for the L183E 1 L192E mutant, the reduction of the interface was also observed but somewhat less pronounced (712 AE 66 Å 2 ). As it is shown in Figure 4 (B), there is a significant structural rearrangement of the a2 helix of conformer B, which contributes to the reduction of the intermolecular interface surface. Although the parallel p-p interaction between H585 (monomer A) and W181 (monomer B) observed in the crystal structure is maintained part of the time, the two residues finally adopt other conformations in which their planes have rotated to be localized more perpendicular to each other [ Fig. 4(D) ]. Within the same simulation times, the wild-type dimer maintains the p-p interaction between H585 (conformer A) and W181 (conformer B) along the whole trajectory, and the hydrophobic interaction on the dimer interface seems to be stable with the interface surface area of 1164 AE 49 Å 2 [ Fig. 4(E) ]. Moreover, the a2 helix opens up as it did in some of our previous trajectories 18 but maintaining the dimer interface.
In summary, our data indicate that allosteric effector 13(S)-HODE shifts the dynamic monomer-dimer equilibrium of 12/15-LOX favoring the formation of transient enzyme dimers. This dimeric complex seems to be also stable in the presence of the bound substrate (AA) as suggested by MD simulations. Interaction between the two flexible surface-exposed a2 helixes suggests that in the transient LOX dimer the two enzyme molecules might work in unison and, therefore, such mode of association might be related to the allosteric character of the enzyme. 16,17 Introduction of negatively charged residues at the intermonomer interface (W181E 1 H585E and L183E 1 L192E mutants) disturbs hydrophobic interactions and leads to functional distortion of the mutant enzyme species. In addition, enzyme dimerization may protect the enzyme from kinetic substrate inhibition by shielding the hydrophobic a2 helixes.
